Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Device for predicting and managing blood glucose by analyzing the effect of, and controlling, pharmacodynamic insulin equivalents

Device for predicting and managing blood glucose by analyzing the effect of, and controlling, pharmacodynamic insulin equivalents

US Patent 8204729 · Granted Jun 19, 2012

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Diaminocyclohexane compounds and uses thereof2014
Indole indane amide compounds useful as CB2 agonists and method2011
Azabicyclic heterocycles as cannabinoid receptor modulators2010
Fluctuating blood glucose notification threshold profiles and methods of use2010
Triazolopyridine cannabinoid receptor 1 antagonists2009
N-sulfonylpiperidine cannabinoid receptor 1 antagonists2009
Triazolopyrimidine cannabinoid receptor 1 antagonists2008
Lactam glycogen phosphorylase inhibitors and method of use2008
Azabicyclic heterocycles as cannabinoid receptor modulators2008
2-Amino-3-functionalized tetralin derivatives and related glycogen phosphorylase2008
Tetrahydroquinoline derivatives as cannabinoid receptor modulators2007
2-amino-4-functionalized tetralin derivatives and related glycogen phosphorylase2007